Leo Wealth, LLC
- SEC CIK
- 0001912202
- Latest filing
- May 5, 2026
The latest 13F from Leo Wealth, LLC covers Q1 2026 (filed May 5, 2026): 452 long positions worth $1.38B. The top 10 holdings make up 33.4% of the portfolio, and the largest is Vanguard World FD at 5.6%. Livermore has 10 filings on Form 13F from this institution, going back to Q4 2023.
What changed in Q1 2026
Share counts compared with Q4 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 65
- Est. +$68.1M
- Added
- 220
- Est. +$83.1M
- Reduced
- 150
- Est. −$82.1M
- Sold out
- 32
- Est. −$24.1M
Top 5 holdings
Share of this quarter's portfolio value
- Vanguard World FD9219107335.6%$77.8M
- Goldman Sachs ETF Tr3814305034.0%$55.4M
- American Centy ETF Tr0250728853.8%$52.5M
- Vanguard World FD9219107253.6%$49.8M
- iShares Tr4642874403.2%$44.3M
Biggest buys
New and added positions, by estimated amount bought
- SPDR Series Trust78464A151+$14.4MNew
- iShares Inc46434G764+$12.3MNew
- iShares Tr46438G430+$11.3MNew
- GEVGE Vernova Inc.
- Janus Detroit STR Tr47103U852+$7.22MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- SPDR Series Trust78464A151+1.04 pp0.0% → 1.0%
- iShares Inc46434G764+0.89 pp0.0% → 0.9%
- iShares Tr46438G430+0.82 pp0.0% → 0.8%
- GEVGE Vernova Inc.
- Janus Detroit STR Tr47103U852+0.51 pp1.4% → 1.9%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- iShares U S ETF Tr46431W705−$23.3MReduced
- Vanguard World FD921910725−$10.6MReduced
- iShares Tr46435G672−$6.58MSold out
- WisdomTree Tr97717Y527−$5.65MReduced
- J P Morgan Exchange Traded F46641Q134−$3.82MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- AFRMAffirm Holdings, Inc.
- iShares U S ETF Tr46431W705−1.71 pp1.8% → 0.1%
- Vanguard World FD921910725−0.76 pp4.4% → 3.6%
- iShares Tr46435G672−0.48 pp0.5% → 0.0%
- Vanguard World FD921910733−0.45 pp6.1% → 5.6%
Metrics
13F metrics for Q1 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $1.38B
- −$1.63M (−0.1%) vs. prior quarter
- Positions
- 452
- +33 vs. prior quarter
- Top 10 concentration
- 33.4%
- Top 10 as share of value
- Turnover
- 7.7%
- Q1 2026, one quarter
- Average holding period
- 7.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.
13F filings by quarter
10 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.38B (Q4 2025)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | 452 | $1.38B | Vanguard World FDGoldman Sachs ETF TrAmerican Centy ETF Tr | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 21, 2026 | 419 | $1.38B | Vanguard World FDAFRMGoldman Sachs ETF Tr | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 286 | $771.3M | AFRMVanguard World FDVanguard World FD | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 24, 2025 | 385 | $1.29B | Vanguard World FDAFRMJNJ | vs. Q1 2025 | SEC |
| Q1 2025 | May 2, 2025 | 269 | $695.7M | JNJAFRMVanguard World FD | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 28, 2025 | 357 | $1.12B | Vanguard World FDAFRMGoldman Sachs ETF Tr | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 21, 2024 | 348 | $1.09B | JNJVanguard World FDGoldman Sachs ETF Tr | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 17, 2024 | 332 | $980.0M | JNJVanguard World FDVanguard World FD | vs. Q1 2024 | SEC |
| Q1 2024 | May 9, 2024 | 333 | $977.2M | JNJVanguard World FDVanguard World FD | vs. Q4 2023 | SEC |
| Q4 2023 | Mar 14, 2024 | 327 | $965.0M | JNJVanguard World FDAFRM | – | SEC |